In the present study, we comprehensively analyzed pan-cancer gene expression profiles that were correlated with RNASEH2A upregulation and we combined stratified survival analyses to identify potential regulatory genes which, together with RNASEH2A, provide great prognostic value for predicting the overall survival rate of cancer patients. The gene discussed is RNASEH2A; the disease is cancer.